Agenda

Wednesday, October 5, 2011

4:00pm	Welcome and Opening Remarks Bruce W. Lytle, MD
Session 1	Overcoming Barriers and Challenges in Translational Research Moderator: Venu Menon, MD and Stephen J. Nicholls, MD, PhD
4:10pm	Is Over - Regulation of the Drug and Device Industry Hurting Innovation? Stephen J. Ubl
4:35pm	The European Perspective Rory Collins, MBBS
4:55pm	The U.S. Perspective Marc S. Sabatine, MD, MPH
5:20pm	Panel Discussion: Session Presenters and Steven Nissen, MD

Thusday, October 6, 2011

Session 2	Structural Heart Disease: Innovations in Intervention Moderator: Joseph F. Sabik, MD and Lars G. Svensson, MD, PhD
A Closer Look at TAVI: Quality, Cost, Appropriateness, and the Future of Percutaneous Valves
8:00am	Will TAVI Lead to Inappropriate Use? E. Murat Tuzcu, MD
8:15am	QOL and Economics David J. Cohen, MD
8:30am	Percutaneous vs Minimally Invasive Surgical AVR-A Look at the Results Gregory Fontana, MD
8:45am	Transcatheter Valves-Where Will We Be in 5 Years? Michael J. Mack, MD
Valve Choice in Children and Young Adults: Tissue or Mechanical
9:00am	The Case for Mechanical Valves Hartzell V. Schaff, MD
9:15am	The Case for Tissue Valves Lawrence Cohn, MD
9:30am	Panel Discussion: Session Presenters and Hani Najm, MD
Session 3	New Frontiers in Preventive Cardiology: The Promise or The Myth? Moderator: Stephen J. Nicholls, MD, PhD and Leslie Cho, MD
9:50am	Do Biomarkers Add Value to Traditional Risk Assessment? Roger S. Blumenthal, MD Paul M. Ridker, MD
10:20am	HDL Function is More Important than the Level Stanley L. Hazen, MD, PhD Stephen J. Nicholls, MD, PhD
10:50am	Inflammation and Artherothrombosis: Where will new trials take us? Paul M. Ridker, MD
11:05am	Panel Discussion: Session Presenters
11:25am	Break
Session 4	AF Management: Current Status and Future Therapeutic Options Moderators: Bruce D. Lindsay, MD and Walid Saliba, MD
11:40am	Anti-thrombotic Therapies: Should We Still Use Warfarin? John R. Bartholomew, MD
Managing AFib
11:55am	Management of Atrial Fibrillation: What is the Role of Medical Therapy vs. Ablation? Douglas L. Packer, MD
12:10pm	New Technologies for Catheter Ablation: Spiraling Costs of Care. Distinguishing Value vs. Unnecessary Cost Hugh Calkins, MD
12:25pm	Do Surgeons Underutilize Operations to Eliminate Atrial Fibrillation? James L. Cox, MD
12:40pm	Panel Discussion: Session Presenters
1:00pm	Lunch
Session 5	Innovations in Heart Failure and MCS Moderators: Randall C. Starling, MD, MPH and James B. Young, MD
Controversies in Cardiac Resynchronization Therapy
2:00pm	When is the Right Time to Use CRT for Heart Failure: Early vs. Later? Michael R. Gold, MD, PhD
2:15pm	What are the Risks of CRT and How Do They Affect Timing of CRT? Bruce L. Wilkoff, MD
2:30pm	Should We Continue to Expand Criteria for Destination Therapy? Rationale, Cost, and Quality of Life Nicholas G. Smedira, MD Marriell L. Jessup, MD
3:00pm	Panel Discussion: Session Presenters
Session 6	Cardiovascular Imaging Moderators: Thomas H. Marwick, MD, PhD and Brian Griffin, MD
3:20pm	The Role of CCTA in Screening in Low Risk Patients Rita F. Redberg, MD Matthew Budoff, MD
3:50pm	Imaging Vulnerable Plaque: Opportunities and Challenges Peter Libby, MD
4:05pm	Panel Discussion: Session Presenters and Steven Nissen, MD, E. Murat Tuczu, MD and Paul Ridker, MD
4:25pm	Break
Session 7	Minimally Invasive Approaches to Treating CV Disease Moderators: E. Murat Tuzcu, MD and Joseph F. Sabik, MD
4:40pm	Percutaneous Repair of the Mitral Valve Should Not Be the First Option A.Marc Gillinov, MD Howard C. Herrmann, MD
5:10pm	Minimally Invasive Approaches Do Not Confer an Advantage Cary W. Akins, MD Tomislav Mihaljevic, MD
5:40pm	Panel Discussion: Session Presenters

Friday, October 7, 2011

Session 8	Hot Topics in Aortic and Vascular Disease Management Moderators: Matthew J. Eagleton, MD and Heather Gornik, MD
8:00am	Advances in Endovascular Aortic Repair: Conquering the Ascending and Aortic Arch - Will Open Surgery Ever Be Necessary Again? Roy K. Greenberg, MD Joseph S. Coselli, MD
8:30am	Repair of Chronic Dissections: Endo versus Open - Which is Safer and Which is More Effective? Joseph Bavaria, MD Eric E. Roselli, MD
9:00am	Peripheral Innovations - Have We Really Made a Difference in Outcomes Carotid Stenting Wesley S. Moore, MD
9:15am	SFA Intervention - Atherectomy, Drug Eluting Balloons, Drug Eluting Stents Daniel G. Clair, MD
9:30am	Panel Discussion: Session Presenters
10:00am	Break
Session 9	Ideal Management of CAD Moderators: Bruce W. Lytle, MD and Samir R. Kapadia, MD
10:00am	Utilizing Imaging to Guide Cost Effective Care Thomas H. Marwick, MD, PhD
Optimal Management Strategies
10:45am	Medical Therapy is Still the Best William S. Weintraub, MD
11:00am	Stents Stephen Ellis, MD
11:15am	Surgery Joseph F. Sabik, MD
11:30am	Bariatric Surgery: The Ultimate Cure for CVD Stacy Brethauer, MD
11:45am	Panel Discussion: Session Presenters and Hani Najm, MD
12:15am	Adjourn